Epilepsy

Treatment options for psychogenic seizures 2:48
Treatment options for psychogenic seizures
Barbara Dworetzky • 24 Mar 2022
Mindfulness-based therapy for PNES 1:56
Mindfulness-based therapy for PNES
Barbara Dworetzky • 24 Mar 2022
Clinical characteristics of patients achieving seizure freedom with adjunctive cenobamate 2:38
Clinical characteristics of patients achieving seizure freedom with adjunctive cenobamate
Christian Brandt • 14 Jun 2022
Diagnostic challenges in adult epilepsy patients with NDDs 2:28
Diagnostic challenges in adult epilepsy patients with NDDs
Christian Brandt • 14 Jun 2022
Novel mechanisms of anti-seizure medications 1:31
Novel mechanisms of anti-seizure medications
Christian Brandt • 14 Jun 2022
Long-term efficacy of adjunctive cenobamate in patients with focal seizures 1:40
Long-term efficacy of adjunctive cenobamate in patients with focal seizures
Christian Brandt • 14 Jun 2022
Epilepsy in adults with neurodevelopmental disabilities: epidemiology & considerations 2:26
Epilepsy in adults with neurodevelopmental disabilities: epidemiology & considerations
Christian Brandt • 14 Jun 2022
Are outcomes of RCTs relevant to treat epilepsy patients or are real-world trials more valuable? 2:57
Are outcomes of RCTs relevant to treat epilepsy patients or are real-world trials more valuable?
Martin Brodie • 23 Mar 2022
The genetics of epilepsy & treatment availability 2:22
The genetics of epilepsy & treatment availability
Martin Brodie • 23 Mar 2022
The need for novel treatments that can modify the development & progression of epilepsy 3:13
The need for novel treatments that can modify the development & progression of epilepsy
Martin Brodie • 23 Mar 2022
Novel agents to control seizures & target epileptogenesis 1:28
Novel agents to control seizures & target epileptogenesis
Claude Steriade • 24 Mar 2022
Proposal for an updated seizure classification framework in clinical trials 2:30
Proposal for an updated seizure classification framework in clinical trials
Claude Steriade • 24 Mar 2022
The diagnosis and treatment of autoimmune-associated seizures 2:32
The diagnosis and treatment of autoimmune-associated seizures
Claude Steriade • 24 Mar 2022
Early and sustained responses to cenobamate across focal seizure subtypes 7:01
Early and sustained responses to cenobamate across focal seizure subtypes
William E. Rosenfeld • 4 Apr 2022
Cenobamate for focal seizures: longer-term efficacy and adverse events 2:55
Cenobamate for focal seizures: longer-term efficacy and adverse events
William E. Rosenfeld • 4 Apr 2022
Cenobamate plasma concentrations in 50% and 100% responders 4:47
Cenobamate plasma concentrations in 50% and 100% responders
William E. Rosenfeld • 4 Apr 2022
The content of VJNeurology is intended for healthcare professionals